Wells Fargo’s ImmuCell ICCC Stock Holding History

Wells Fargo’s Portfolio ICCC Stock Details ICCC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7	Hold	1	–	–	﹤0.01%	7117
2026 Q1	$4	Hold	1	–	–	﹤0.01%	7044
2025 Q4	$4	Hold	1	–	–	﹤0.01%	6978
2025 Q3	$4	Hold	1	–	–	﹤0.01%	6946
2025 Q2	$5	Hold	1	–	–	﹤0.01%	6989
2025 Q1	$3	Hold	1	–	–	﹤0.01%	6924
2024 Q4	$4	Hold	1	–	–	﹤0.01%	6931
2024 Q3	$3	Hold	1	–	–	﹤0.01%	6808
2024 Q2	$3	Sell	1 -2,543	-100%	-$12.2K	﹤0.01%	6773
2024 Q1	$13.5K	Buy	2,544 +2	+0.1%	+$10	﹤0.01%	5678
2023 Q4	$12.9K	Buy	2,542 +2,502	+6,255%	+$12.2K	﹤0.01%	5759
2023 Q3	$214	Hold	40	–	–	﹤0.01%	6564
2023 Q2	$200	Buy	40 +2	+5%	+$10	﹤0.01%	6705
2023 Q1	$196	Buy	38 +1	+3%	+$6	﹤0.01%	6775
2022 Q4	$226	Hold	37	–	–	﹤0.01%	6592
2022 Q3	$0	Hold	37	–	–	﹤0.01%	6950
2022 Q2	$0	Buy	37 +3	+9%	+$26	﹤0.01%	7092
2022 Q1	$0	Hold	34	–	–	﹤0.01%	7388
2021 Q4	$0	Hold	34	–	–	﹤0.01%	7481
2021 Q3	$0	Sell	34 -2	-6%	-$19	﹤0.01%	7209
2021 Q2	$0	Buy	36 +2	+6%	+$20	﹤0.01%	7130
2021 Q1	$0	Buy	34 +2	+6%	+$19	﹤0.01%	7088
2020 Q4	$0	Hold	32	–	–	﹤0.01%	6709
2020 Q3	$0	Sell	32 -3	-9%	-$17	﹤0.01%	6569
2020 Q2	$0	Hold	35	–	–	﹤0.01%	6518
2020 Q1	$0	Buy	+35	New	+$172	﹤0.01%	6459
2019 Q3	–	Sell	-1,950	Closed	-$13K	–	6527
2019 Q2	$13K	Buy	+1,950	New	+$12.4K	﹤0.01%	5858
2019 Q1	–	Sell	-1	Closed	–	–	6227
2018 Q4	$0	Hold	1	–	–	﹤0.01%	6496
2018 Q3	$0	Sell	1 -1,000	-100%	-$7.2K	﹤0.01%	6476
2018 Q2	$7K	Sell	1,001 -33,000	-97%	-$237K	﹤0.01%	6032
2018 Q1	$238K	Buy	34,001 +11,000	+48%	+$80.5K	﹤0.01%	4885
2017 Q4	$202K	Sell	23,001 -1,701	-7%	-$13.9K	﹤0.01%	4956
2017 Q3	$161K	Buy	24,702 +1,701	+7%	+$11.1K	﹤0.01%	5025
2017 Q2	$169K	Hold	23,001	–	–	﹤0.01%	4886
2017 Q1	$127K	Sell	23,001 -1,000	-4%	-$5.75K	﹤0.01%	5086
2016 Q4	$143K	Buy	24,001 +23,000	+2,298%	+$140K	﹤0.01%	4942
2016 Q3	$8K	Hold	1,001	–	–	﹤0.01%	5809
2016 Q2	$7K	Buy	1,001 +1,000	+100,000%	+$6.75K	﹤0.01%	5748
2016 Q1	$0	Hold	1	–	–	﹤0.01%	6298
2015 Q4	$0	Hold	1	–	–	﹤0.01%	6313
2015 Q3	$0	Hold	1	–	–	﹤0.01%	6305
2015 Q2	$0	Hold	1	–	–	﹤0.01%	6420
2015 Q1	$0	Hold	1	–	–	﹤0.01%	6250
2014 Q4	$0	Sell	1 -2	-67%	-$10	﹤0.01%	6296
2014 Q3	$0	Sell	3 -1,998	-100%	-$9.34K	﹤0.01%	6240
2014 Q2	$9K	Buy	2,001 +2,000	+200,000%	+$8.42K	﹤0.01%	5668
2014 Q1	$0	Hold	1	–	–	﹤0.01%	5958
2013 Q4	$0	Hold	1	–	–	﹤0.01%	5821
2013 Q3	$0	Hold	1	–	–	﹤0.01%	5734
2013 Q2	$0	Buy	+1	New	+$4	﹤0.01%	5636

Other funds holding ICCC

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

CAM

Cresset Asset Management Chicago, Illinois $27.6B AUM 31.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return

Steadtrust Allen, Texas $198M AUM 99.37% 1-Year Est. Return

MFIM

Mesirow Financial Investment Management Chicago, Illinois $6.37B AUM 23.22% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Wells Fargo's ICCC Position: Q2 2026 in Review

Wells Fargo held its ImmuCell (ICCC) position steady in Q2 2026 at 1 share worth $7. The position accounts for ﹤0.01% of the portfolio, ranked #7117.

Wells Fargo first reported a position in ICCC in Q2 2013 and has held it in 50 quarters since. The position peaked at $238K in Q1 2018. 31 funds tracked by Wall St. Rank hold ICCC as of Q2 2026.

Wells Fargo held 1 share of ImmuCell worth $7 as of Q2 2026.
Wells Fargo left its ImmuCell share count unchanged in Q2 2026.
ImmuCell made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #7117 holding.
Wells Fargo first reported a position in ImmuCell in Q2 2013 and has held it in 50 quarters since.
Wells Fargo's ImmuCell position peaked at $238K in Q1 2018.
31 funds tracked by Wall St. Rank held ImmuCell as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.